Understanding the variability in ketamine’s efficacy in managing treatment-resistant depression
This review looks at why ketamine helps some people with treatment‑resistant depression more than others. Ketamine blocks NMDA receptors, which can quickly boost glutamate signaling, promote new synapses, and reverse stress‑related brain changes. It often works faster than standard antidepressants and has a generally favourable safety profile, but how well…
